Experience and expectations of pharmacogenetic tests in France

The Critical Role of Pharmacists in the Clinical Delivery of Pharmacogenetics in the U.S

“…Thus, the initiation of the PGx testing process may warrant authorization from the prescriber if the pharmacist is not an authorized provider. However, the reported limited understanding of physicians [7,[91][92][93][94][95][96][97][98] and differences in the perceived benefits of PGx testing between physicians and pharmacists pose challenges to pharmacist-initiated PGx testing [89]. In contrast to a team-based clinical setting, the community pharmacist may or may not have a relationship with the prescribing provider, but may have a very close relationship with the customer/patient, as noted earlier.…”

“…In one program, a hospital pharmacist and prescriber jointly reviewed patients' PGx test results with their full medical histories to determine if medication changes were needed [104]. The lack of provider acceptance may be due to lack of prescriber knowledge about PGx testing [7,84,[91][92][93][94][95][96][97][98]105] and the unclear roles involved in the delivery of PGx testing. To address this challenge, one pharmacist-led consultation service included physician education as a part of their service to help physicians identify patients likely to benefit from PGx testing and promote therapeutic decision-making based on PGx test results [43].…”